DSG2 Gene Cardiomyopathy Dilated Type 1BB NGS Genetic DNA Test
Comprehensive Genetic Screening for Inherited Heart Conditions
The DSG2 Gene Cardiomyopathy Dilated Type 1BB NGS Genetic DNA Test represents a breakthrough in cardiac genetic diagnostics, offering precise detection of mutations in the desmoglein-2 (DSG2) gene associated with dilated cardiomyopathy. This advanced genetic screening utilizes cutting-edge Next Generation Sequencing technology to identify specific genetic variants that can predispose individuals to progressive heart muscle weakening and cardiac dysfunction.
What Does This Test Measure?
This comprehensive genetic analysis specifically targets the DSG2 gene, which encodes the desmoglein-2 protein crucial for maintaining the structural integrity of cardiac muscle cells. The test detects:
- Pathogenic mutations in the DSG2 gene associated with dilated cardiomyopathy type 1BB
- Single nucleotide variants (SNVs) and small insertions/deletions (indels)
- Genetic variations affecting desmosomal protein function
- Inherited patterns of cardiac disease susceptibility
Who Should Consider This Test?
This genetic screening is particularly recommended for individuals experiencing:
- Unexplained heart failure symptoms at a young age
- Family history of dilated cardiomyopathy or sudden cardiac death
- Abnormal echocardiogram findings without clear cause
- Progressive cardiac enlargement or reduced ejection fraction
- Multiple family members with cardiac conduction abnormalities
- Personal history of arrhythmias with structural heart changes
Clinical Benefits of Genetic Testing
Early detection through DSG2 genetic testing provides numerous advantages:
- Proactive Management: Enables early intervention before significant cardiac damage occurs
- Family Screening: Identifies at-risk relatives for preventive monitoring
- Personalized Treatment: Guides medication selection and lifestyle recommendations
- Reproductive Planning: Informs family planning decisions for inherited conditions
- Risk Stratification: Helps determine appropriate surveillance frequency
Understanding Your Test Results
Your genetic test results will fall into one of several categories:
- Positive Result: Indicates a pathogenic DSG2 mutation is present, requiring comprehensive cardiac evaluation and family member screening
- Negative Result: Suggests no known pathogenic DSG2 mutations were detected, though continued cardiac monitoring may still be recommended based on clinical findings
- Variant of Uncertain Significance (VUS): Identifies a genetic change whose clinical significance is currently unknown, requiring ongoing research and periodic re-evaluation
Test Pricing Information
| Price Type | Amount (USD) |
|---|---|
| Discount Price | $500 |
| Regular Price | $700 |
Nationwide Testing Availability
We proudly serve patients across the United States with convenient testing locations in major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our network of certified genetic counselors and cardiology specialists ensures comprehensive care coordination regardless of your location.
Take Control of Your Cardiac Health
Don’t wait for symptoms to progress. Early genetic detection of DSG2 cardiomyopathy can significantly impact your long-term cardiac health outcomes. Our team of genetic specialists and cardiologists are ready to guide you through the testing process and provide personalized recommendations based on your results.
Call us today at +1(267) 388-9828 to schedule your genetic counseling session and book the DSG2 Gene Cardiomyopathy Dilated Type 1BB NGS Genetic DNA Test. Take the first step toward understanding your genetic cardiac risk and protecting your heart health for years to come.
